Cargando…

Advances in sepsis-associated liver dysfunction

Recent studies have revealed liver dysfunction as an early event in sepsis. Sepsis-associated liver dysfunction is mainly resulted from systemic or microcirculatory disturbances, spillovers of bacteria and endotoxin (lipopolysaccharide, LPS), and subsequent activation of inflammatory cytokines as we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dawei, Yin, Yimei, Yao, Yongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012093/ https://www.ncbi.nlm.nih.gov/pubmed/27602369 http://dx.doi.org/10.4103/2321-3868.132689

Ejemplares similares

Time-resolved single-cell transcriptomics reveals the landscape and dynamics of hepatic cells in sepsis-induced acute liver dysfunction
por: Chen, Gan, et al.
Publicado: (2023)

Neutrophil Dysfunction in Sepsis
por: Zhang, Fang, et al.
Publicado: (2016)

Gut-liver crosstalk in sepsis-induced liver injury
por: Sun, Jian, et al.
Publicado: (2020)

COVID-19-Associated Acute Brain Dysfunction Related to Sepsis
por: Tong, Dao Ming, et al.
Publicado: (2021)

Pathophysiology of sepsis-induced myocardial dysfunction
por: Lv, Xiuxiu, et al.
Publicado: (2016)

Potential therapy strategy: targeting mitochondrial dysfunction in sepsis
por: Zhang, Hui, et al.
Publicado: (2018)

Understanding brain dysfunction in sepsis
por: Sonneville, Romain, et al.
Publicado: (2013)

Recent advances in the study of sepsis-induced depression
por: Wang, Yunyun, et al.
Publicado: (2023)

Sepsis-Associated Brain Dysfunction: A Review of Current Literature
por: Czempik, Piotr F., et al.
Publicado: (2020)

Research Advances in the Subtype of Sepsis-Associated Thrombocytopenia
por: Wu, Xinghui, et al.
Publicado: (2020)

Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis
por: Suzuki, Takeshi, et al.
Publicado: (2017)

Microvascular dysfunction as a cause of organ dysfunction in severe sepsis
por: Vincent, Jean-Louis, et al.
Publicado: (2005)

Histopathological changes of organ dysfunction in sepsis
por: Garofalo, Antonio M., et al.
Publicado: (2019)

Omics of endothelial cell dysfunction in sepsis
por: Langston, Jordan C, et al.
Publicado: (2022)

The roles of tissue-resident macrophages in sepsis-associated organ dysfunction
por: Gao, Yulei, et al.
Publicado: (2023)

Role of Exogenous Hsp72 on Liver Dysfunction during Sepsis
por: Tsai, Tsen-Ni, et al.
Publicado: (2015)

New Translational Research Provides Insights into Liver Dysfunction in Sepsis
por: Marshall, John C.
Publicado: (2012)

Monoethylglycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis
por: Esen, F, et al.
Publicado: (1997)

The liver in sepsis: shedding light on the cellular basis of hepatocyte dysfunction
por: Marshall, John C
Publicado: (2013)

Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence
por: Zhou, Gaosheng, et al.
Publicado: (2022)

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
por: Sangro, Paloma, et al.
Publicado: (2023)

Continuous hemofiltration improves the prognosis of bacterial sepsis complicated by liver dysfunction in children
por: Cui, Yun, et al.
Publicado: (2018)

Sepsis-induced myocardial dysfunction: pathophysiology and management
por: Kakihana, Yasuyuki, et al.
Publicado: (2016)

Energetic dysfunction in sepsis: a narrative review
por: Preau, Sebastien, et al.
Publicado: (2021)

Role of heparinase in the gastrointestinal dysfunction of sepsis (Review)
por: Chen, Ting-Ting, et al.
Publicado: (2022)

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study
por: Woźnica-Niesobska, Ewa, et al.
Publicado: (2023)

Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation
por: Anderko, Renee R., et al.
Publicado: (2022)

Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis
por: Tanaka, Sébastien, et al.
Publicado: (2022)

Advances in the Study of Immunosuppressive Mechanisms in Sepsis
por: Fu, Xuzhe, et al.
Publicado: (2023)

Clinical review: The liver in sepsis
por: Nesseler, Nicolas, et al.
Publicado: (2012)

Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis
por: Park, Dae Won, et al.
Publicado: (2017)

Cerebral dysfunctions caused by sepsis during ageing
por: Manabe, Tatsuya, et al.
Publicado: (2021)

Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment
por: Pan, Shangwen, et al.
Publicado: (2022)

Association between Elevated Serum Tau Protein Level and Sepsis-Associated Encephalopathy in Patients with Severe Sepsis
por: Zhao, Teng, et al.
Publicado: (2019)

Neuregulin-1: An underlying protective force of cardiac dysfunction in sepsis
por: Kang, Wen, et al.
Publicado: (2020)

Association Between Gut Dysbiosis and Sepsis-Induced Myocardial Dysfunction in Patients With Sepsis or Septic Shock
por: Chen, Yu, et al.
Publicado: (2022)

Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction
por: Wen, Ri, et al.
Publicado: (2022)

Metabolic reprogramming consequences of sepsis: adaptations and contradictions
por: Liu, Jingjing, et al.
Publicado: (2022)

Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
por: Zhang, Hao, et al.
Publicado: (2023)

Organ dysfunction as a new standard for defining sepsis
por: Fujishima, Seitaro
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tg4m7ij41ra9msu5t6n56ft9a5